Effectiveness of coenzyme Q10 on learning and memory and synaptic plasticity impairment in an aged Aβ-induced rat model of Alzheimer’s disease: a behavioral, biochemical, and electrophysiological study

被引:0
作者
Masoumeh Asadbegi
Hamidreza Komaki
Nafiseh Faraji
Masoumeh Taheri
Samaneh Safari
Safoura Raoufi
Masoumeh Kourosh-Arami
Zoleikha Golipoor
Alireza Komaki
机构
[1] Hamadan University of Medical Sciences,Neurophysiology Research Center
[2] Hamadan University of Medical Sciences,Department of Neuroscience, School of Science and Advanced Technologies in Medicine
[3] Hamadan University of Medical Sciences,Department of Physiology, School of Medicine
[4] Iran University of Medical Sciences,Department of Neuroscience, School of Advanced Technologies in Medicine
[5] Guilan University of Medical Sciences,Cellular and Molecular Research Center, Faculty of Medicine
来源
Psychopharmacology | 2023年 / 240卷
关键词
Alzheimer’s disease; Coenzyme Q10; Hippocampus; Synaptic plasticity; Dentate gyrus; Amyloid-beta; Aging;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:951 / 967
页数:16
相关论文
共 464 条
[11]  
Biala G(1999)[2] Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration Methods Enzymol 299 15-27
[12]  
Asadbegi M(2000)Cognitive decline is associated with systemic oxidative stress: the EVA study J Am Geriatr Soc 48 1285-1291
[13]  
Komaki A(2004)Chronic stress alters amphetamine effects on behavior and synaptophysin levels in female rats Pharmacol Biochem Behav 78 541-550
[14]  
Salehi I(2008)Neural response to self-and other referential praise and criticism in generalized social phobia Arch Gen Psychiatry 65 1176-1184
[15]  
Yaghmaei P(2020)Complex clearance mechanisms after intraventricular hemorrhage and rt-PA treatment—a review on clinical trials Transl Stroke Res 11 337-344
[16]  
Ebrahim-Habibi A(2010)Exogenous antioxidants—double-edged swords in cellular redox state: health beneficial effects at physiologic doses versus deleterious effects at high doses Oxid Med Cell Longev 3 228-237
[17]  
Shahidi S(2016)Neuroinflammation in Alzheimer’s disease: current evidence and future directions Alzheimers Dement 12 719-732
[18]  
Sarihi A(2001)The amyloid-β peptide and its role in Alzheimer’s disease J Pept Sci 7 227-249
[19]  
Asl SS(2015)Assessing rodent hippocampal involvement in the novel object recognition task. A review Behav Brain Res 285 105-117
[20]  
Golipoor Z(2000)The role of cholinergic agents in the management of behavioural disturbances in Alzheimer’s disease Int J Neuropsychopharmacol 3 S21-S29